Endothelial release of tissue-type plasminogen activator (t-PA) regulates fibrinolysis and is considered a primary endogenous defense mechanism against thrombosis. Adiposity is associated with an increased risk of atherothrombotic events. We determined the influence of overweight and obesity on the capacity of the vascular endothelium to release t-PA and the effects of regular aerobic exercise on endothelial t-PA release in previously sedentary overweight and obese adults. First, we studied 66 sedentary adults: 28 normal weight (< 25 kg/m 2 ); 22 overweight (BMI > 25 < 30 kg/m 2 ) and 16 obese (BMI: > 30 kg/m 2 ). Net endothelial t-PA release was determined in vivo in response to intrabrachial infusions of bradykinin and sodium nitroprusside. Second, we studied 17 overweight and obese adults who completed a 3-month aerobic exercise intervention. Net release of t-PA in response to BK was 45% lower (P<0.01) in overweight (from 0.1+0.4 to 41.7+4.9 ng/100 mL tissue/min) and obese (0.1+ 0.6 to 47.7+5.2 ng/100 mL tissue/min) compared with normal weight (0.1+0.8 to 77.5+6.7
Recent estimates indicate that over 60% of the adult population in the United States is either overweight or obese (21) . Moreover, the incidence of overweight and obesity is highest in middle-aged and older adults and is thought to contribute to the increased risk of coronary artery disease, cerebrovascular disease and atherothrombotic events in this segment of the population (37, 39, 40) .
It is now well accepted that endothelial dysfunction plays an important role in the initiation and progression of atherosclerosis (5, 45) . A potential mechanism underlying the heightened atherothrombotic risk with obesity is impaired endothelial control of fibrinolysis. Endothelial cells are the principal site of synthesis and release of tissue-type plasminogen activator (t-PA), the key enzyme in initiating an endogenous fibrinolytic response due to its ability to preferentially activate plasminogen on the surface of developing thrombi (15) . Experimental and clinical data indicate that it is the capacity of the endothelium to release t-PA rapidly and acutely from intracellular storage pools and not circulating plasma fibrinolytic concentrations that determines the efficacy of endogenous fibrinolysis (14, 42) . Indeed, the thrombolytic potential of t-PA is greatest if it is readily available and incorporated during, rather than after, thrombus formation (4, 22) . Moreover, diminished endothelial t-PA release has been linked with accelerated thrombogenesis (6, 10) . Currently it is unknown whether the capacity of the endothelium to acutely release t-PA is compromised in overweight and obese adult humans. If so, this may contribute mechanistically to their increased risk of thrombosis.
Regular aerobic exercise is associated with a reduction in cardiovascular events in overweight and obese adults independent of weight loss (2) . One of the possible mechanisms by which regular aerobic exercise confers this cardioprotection is via its availing effects on endothelial function. Indeed, improved endothelial vasomotor function has been linked to a reduction in cardiovascular events (32) . Exercise-induced enhancement in the capacity of the endothelium to release t-PA may also contribute to the reduced cardiovascular risk observed in physically active overweight adults (32) . Accordingly, we tested the following hypotheses: 1) the capacity of the vascular endothelium to acutely release t-PA is impaired in overweight and obese adults; and 2) regular aerobic exercise training would improve endothelial t-PA release in previously sedentary overweight and obese adults. To address these hypotheses we employed both cross-sectional and intervention study designs. First, we used a cross-sectional model to determine the influence of overweight and obesity on the capacity of the endothelium to release t-PA. We then performed an intervention study to determine the effects of moderate aerobic exercise training on endothelial t-PA release rates in sedentary overweight and obese adults.
METHODS

Subjects
Cross-Sectional Study . Sixty-six sedentary adults (37 male/29 females) were studied : 28 normal weight (BMI < 25 kg/m 2 ); 22 overweight (BMI > 25 < 30 kg/m 2 ) and 16 obese (BMI > 30 kg/m 2 ). All subjects were sedentary and had not participated in a regular aerobic exercise program for at least 2 years prior to the start of the study. Subjects were excluded from the study if they presented a history or evidence of: hepatic, renal, or hematological disease; peripheral vascular disease; stroke; diabetes (fasting plasma glucose > 7.0 mmol/L) (1); dyslipoproteinemia (total cholesterol > 6.0 mmol/L, LDL-cholesterol > 4.5 mmol/L, triglycerides > 2.5 mmol/L) (19) ; and hypertension (BP>140/90 mm Hg) (9) . All subjects were screened for clinical evidence of coronary artery disease with resting and maximal exercise electrocardiograms and blood pressure. None of the subjects smoked or were taking medication including vitamins. All of the women were at least 1 year postmenopausal (mean: 7+1 years) and had never taken or had discontinued use of hormone replacement therapy at least 1 year before the start of the study.
Prior to participation, all of the subjects had the research study and its potential risks and benefits explained fully before providing written informed consent according to the guidelines of the University of Colorado at Boulder.
Intervention Study. Seventeen of the 38 overweight and obese adults (11 M/6 F) who participated in the cross-sectional study enrolled in a 3-month aerobic exercise training program.
All baseline measures were subsequently repeated in these subjects after the exercise intervention.
Measurements
Body Composition. Body mass was measured to the nearest 0.1 kg using a medical beam balance (Detecto, Webb City, MO). Percent body fat was determined by dual energy x-ray absorptiometry (Lunar Radiation Corporation, Madison, WI). Body mass index (BMI) was calculated as weight (kilograms) divided by height (meters) squared. Minimal waist circumference was measured according to previously published guidelines (33) .
Treadmill Exercise Test.
To assess aerobic fitness subjects performed incremental treadmill exercise using a modified Balke protocol as previously described (11 and <8%, respectively.
Intra-Arterial Fibrinolytic Protocol. All measurements were performed in a temperature-controlled room between 7 and 10 AM after a 12-hour overnight fast as previously described by our laboratory (24, 48) . Briefly, an intravenous catheter was placed in a deep antecubital vein of the nondominant arm. Thereafter, a 5-cm, 20-gauge catheter was introduced into the brachial artery of the same arm under local anesthesia (1% lidocaine). Forearm blood flow (FBF) was measured using strain-gauge venous occlusion plethysmography (D.E.
Hokanson, Bellevue, WA) and presented as mL/100 mL forearm volume/min. Following the measurement of resting blood flow for 5 minutes, bradykinin was infused intra-arterially at rates of 12.5, 25, 50 ng/100 mL tissue/min and sodium nitroprusside at 1.0, 2.0, 4.0 µg/100 mL tissue/min for 5 min at each dose as previously described (24) . To avoid an order effect the sequence of drug administration was randomized. Forearm volume was determined by the water displacement method.
Net endothelial release of t-PA antigen and PAI-1 antigen in response to bradykinin and sodium nitroprusside was calculated according to Jern et al. (27) using the following equation:
where C V and C A represent the concentration in the vein and artery, respectively. For both t-PA and PAI-1, a positive difference indicated a net release and a negative difference, net uptake.
Arterial and venous blood samples were collected simultaneously at baseline and the end of each drug dose. t-PA and PAI-1 antigen concentrations were determined by enzyme immunoassay.
Hematocrit was measured in triplicate using the standard microhematocrit technique and corrected for trapped plasma volume within the trapped erythrocytes (8) . The total amount of t-PA antigen released across the forearm in response to bradykinin was calculated as the total area under each curve above baseline using a trapezoidal model. In order to avoid confounding effects from potential infection/inflammation associated fibrinolytic changes all subjects were free of recent infection/inflammation (< 2 weeks) as determined by questionnaire (34) .
Exercise Intervention
The 3-month home-based aerobic exercise-training program employed in the present study has been described previously by our laboratory (11) . Briefly, after completion of baseline measurements, subjects underwent a supervised orientation, after which they exercised on their own. Subjects were asked to exercise 5-7 days per week, 40-50 minutes per day, at 60-75% of their individual maximum heart rate determined during maximal exercise testing. Most subjects walked, but some integrated jogging into their exercise session, as their fitness improved, in order to maintain their heart rate within the prescribed range. Compliance to the exercise program was documented every 2 weeks using data downloaded directly from heart rate monitors (Polar Electro Inc., Woodbury, NY, USA) and from exercise logs.
Statistical Analysis
Differences in subject baseline characteristics and area under the curve data were determined by between-groups analysis of variance (ANOVA). Group differences in FBF and endothelial t-PA and PAI-1 antigen release in response to bradykinin and sodium nitroprusside were determined by repeated measures ANOVA. When indicated by a significant F value, a post hoc test using Newman-Keuls method was performed to identify differences amongst the groups.
Relations between variables of interest were assessed by means of Pearson's correlation coefficient and linear regression analysis. Changes in the dependent variables resulting from the exercise intervention were assessed by repeated measures ANOVA. Importantly, there were no significant gender interactions in any of the key outcome variables, therefore the data were pooled and presented together. Because of the skewed distribution of plasma CRP concentrations, the data were log transformed to satisfy basic assumptions for parametric testing. Forearm blood flow responses to bradykinin were significantly lower (~20%) in the overweight and obese compared with normal weight subjects. There were no significant differences among the groups in the forearm vasodilator responses to sodium nitroprusside (Table 3 ).
RESULTS
Cross-Sectional Study
Basal endothelial t-PA antigen release was not significantly different among the groups.
However, the capacity of the endothelium to release t-PA in response to bradykinin stimulation was significantly blunted in the overweight and obese adults ( Figure 1 ). Net release of t-PA antigen was ~45% less (P<0.01) in the overweight (from 0.1+0.4 to 41.7+4.9 ng/100 mL tissue/min) and obese (from -0.1+ 0.6 to 47.7+5.2 ng/100 mL tissue/min) compared with normal weight (from 0.1+0.8 to 77.5+6.7 ng/100 mL tissue/min) subjects. As a result, the total amount of t-PA antigen released (area under the curve) was much lower (P<0.01) in the overweight (210+23 ng/100 mL tissue) and obese (224+22 ng/100 mL tissue) than normal weight (395+34 ng/100 mL tissue) adults (Figure 3 ). There were no significant differences in either the rate or total amount of t-PA release between the overweight and obese adults. Infusion of sodium nitroprusside did not stimulate significant increases in t-PA release in either the normal weight (-0.6+0.5 to 3.7 ng/100 mL tissue/min), overweight (from 1.7+1.1 to 1.8+2.8 ng/100 mL tissue/min) or obese (from -0.1+0.4 to 2.1+2.3 ng/100 mL tissue/min) groups. Of note, neither bradykinin nor sodium nitroprusside elicited consistent or significant changes in PAI-1 antigen release in any of the groups. Marginal release was observed at the highest dose of bradykinin in the normal weight (3.8+3.7 ng/100 mL tissue/min), overweight (6.0+2.4 ng/100 mL tissue/min) and obese (1.3+3.9 ng/100 mL tissue/min) groups.
In the overall study population the total amount of t-PA antigen released in response to bradykinin was significantly related to body mass (r=-0.40), percent fat (r=-0.29) and BMI (r=-0.47), waist circumference (r=-0.28), plasma insulin (r=-0.36), plasma glucose (r=-0.55),
HOMA-IR (r=-0.39) and IL-18 (r=-0.29).
Exercise Intervention Study
All 17 overweight and obese adults (age 57 + 1 years) completed the 3-month exercise intervention study. Subjects exercised an average of 5.0+0.3 days/week, for 44+2 min/day at an intensity of 68+1% of maximal heart rate. There were no significant changes in body mass, adiposity, heart rate at rest, arterial blood pressure, V . O 2 max, plasma cholesterol, glucose or insulin concentrations and HOMA-IR levels (Table 4) . However, aerobic exercise training increased exercise time to exhaustion by ~20% (P<0.01), and significantly decreased heart rate and ratings of perceived exertion at the same absolute submaximal level of exercise (~70% of baseline maximal oxygen consumption). Plasma concentrations of CRP, IL-6, IL-18 and TNF-α were not affected by exercise training ( Table 2 ). In addition, FBF responses to bradykinin and sodium nitroprusside were not significantly different after exercise training (Table 3 ).
Basal release rates of t-PA antigen did not significantly change with exercise training.
However, net endothelial t-PA release rates in response to bradykinin were markedly higher (P<0.01) after (from 1.2+1.0 to 66.4+6.6 ng/100 mL tissue/min) versus before (from 1.0+0.9 to 65.4+6.3 ng/100 mL tissue/min) versus before (-0.3+0.5 to 37.1+4.9 ng/100 mL tissue/min) exercise training.
As a result, the total amount of t-PA antigen released (area under the curve) to bradykinin increased 55% (from 208+21 to 320+31 ng/100 mL tissue; P<0.01) with the exercise intervention ( Figure 2 ).
There was no change in t-PA antigen release to sodium nitroprusside in response to exercise.
Moreover, net release rates of PAI-1 antigen were not significantly different after exercise training.
There were no significant relations were observed between metabolic and inflammatory factors and the exercise-induced improvement in endothelial t-PA release.
DISCUSSION
The primary new findings of the present study are that: 1) the capacity of the endothelium to release t-PA is blunted in middle-aged overweight and obese adults compared with their normal weight peers; and 2) moderate aerobic exercise training, independent of weight loss, can improve the ability of the endothelium to release t-PA in previously sedentary overweight and obese adults. Endothelial fibrinolytic dysfunction may underlie the increased risk of thrombotic events associated with overweight and obesity. Importantly, however, this critical aspect of endothelial function can be improved in overweight and obese adults with regular aerobic exercise.
Overweight and obesity have been associated with increased cardiovascular morbidity and mortality (39, 40) resulting from atherothrombotic events. Indeed, overweight persons demonstrate accelerated atherosclerosis (36) , and increased rates of myocardial infarction and stroke (40) . In addition, excess adiposity has been linked to an increased risk of recurrent coronary events following an acute myocardial infarction (46, 50) . The mechanisms underlying this thrombotic tendency are not completely understood. Much attention has focused on the effects of adiposity on the fibrinolytic system, specifically differences in plasma concentrations of t-PA antigen and PAI-1 antigen in obese and normal weight adults (17, 31, 47) . However, systemic fibrinolytic concentrations provide an indirect, non-specific, and in some cases misleading, assessment of vascular fibrinolytic potential (26, 27) . Plasma concentrations of t-PA and PAI-1 are highly dependent on the rate of t-PA/PAI-1 complex formation and, in turn, hepatic clearance (41) . Moreover, we (23, 48) and others (27) have demonstrated that circulating t-PA and PAI-1 concentrations do not reflect the capacity of the endothelium to acutely release t-PA, the primary determinant of endogenous fibrinolytic activity.
The results of the present study demonstrate, for the first time, that the ability of the endothelium to release t-PA is markedly reduced in both overweight and obese adults. Both the rate and total amount of t-PA antigen released from the endothelium in response to bradykinin were ~50% lower in the overweight and obese adults compared with normal weight controls of similar age. This loss in endothelial fibrinolytic function may have important clinical consequences. Indeed, the ability of endothelial cells to release t-PA is a vital defense mechanism against thrombosis; disruption of this process is considered to be an important antecedent to atherothrombotic disease (38, 41) . For example, in animal models, t-PA deficient mice demonstrate accelerated atherosclerotic fibrin deposition and extensive myocardial tissue necrosis (6, 10) . In humans, reduced endothelial t-PA release rates have been linked to increased atheromatous plaque in cigarette smokers and myocardial infarctions in patients with acute coronary syndromes (25) . Thus, impaired endothelial release of t-PA may be an important factor underlying the prothrombotic state associated with overweight and obesity.
The mechanisms responsible for impaired endothelial t-PA release in overweight and obese adults are not clear. Although, the FBF responses to bradykinin were significantly lower in the overweight and obese subjects compared with normal weight controls, it is unlikely that the overweight/obesity-related differences in endothelial t-PA release was a blood flow related phenomenon. Consistent with previous studies (24, 27, 48) we observed no significant effect of sodium nitroprusside on t-PA antigen release across the forearm despite a marked increase in limb blood flow in each group. In addition, we observed no correlation between bradykinininduced changes in blood flow and t-PA release in either the overweight, obese or normal weight groups. The lack of differences in PAI-1 antigen release among the groups in response to bradykinin rules out the potential confounding effects of t-PA/PAI-1 complex formation. It has been suggested that increased inflammatory burden may contribute to the heightened risk of atherothrombosis with obesity (16, 52) . Indeed, inflammatory mediators such as CRP, IL-6 and IL-18 have been linked to arterial thrombogenesis (3, 51) . Although the overweight and obese subjects in the present study demonstrated significantly higher plasma concentrations of CRP, IL-18 and TNF-α compared with the normal weight controls, only a weak relation (r=-0.29), albeit significant, was observed with IL-18 and endothelial t-PA release. Neither CRP, IL-6 nor TNF-α was associated with t-PA release. Based on these correlative findings it would be unreasonable to dismiss the possibility that local inflammatory processes at the vascular wall may adversely affect endothelial function. However, the results of the present study indicate that impaired endothelial t-PA release in overweight and obese adults is largely unrelated to circulating inflammatory proteins. It is possible that overweight/obesity-related increases in oxidative stress may contribute to diminished endothelial t-PA release. Ex vivo studies have shown that oxidative stress not only inhibits t-PA release from cultured endothelial cells but also damages the fibrin-binding affinity of t-PA reducing its thrombolytic capacity (20, 30) . In vivo, oxidative stress has been linked to impaired endothelial vasodilator function in overweight adults (44) and may also negatively impact endothelial t-PA release. We are currently investigating the effects of oxidative stress on endothelial t-PA release in obese adults.
It is important to note, that the overweight and obese subjects in the present study were free of the cardiovascular and metabolic abnormalitites that often accompany excess body fatness such as clinically overt coronary artery disease, hypertension, type 2 diabetes, dyslipidemia and hyperinsulinemia (7) . Thus, it is tempting to speculate that diminished endothelial t-PA release may be a primary consequence of overweight or obesity. However, in addition to being overweight or obese the subjects in the present study were sedentary. We have previously demonstrated that a sedentary lifestyle is associated with impaired endothelial release of t-PA (48) . Moreover, epidemiological studies suggest that physical inactivity may contribute significantly to the increased cardiovascular risk with overweight and obesity. Indeed, the prevalence of cardiovascular and metabolic abnormalities has been shown to be lower in overweight and obese adults who engage in regular physical activity (18, 28) . The results of our exercise intervention study support this notion and demonstrate that impaired endothelial t-PA release is not an unavoidable consequence of overweight and obesity.
Indeed, 3 months of moderate aerobic exercise training (primarily walking) resulted in a marked improvement in the capacity of the endothelium to release t-PA in previously sedentary overweight and obese adults. The rate and total amount of t-PA antigen released across the forearm in response to bradykinin increased by more than 50% after exercise training and, notably, were no longer significantly different from the levels observed in the normal weight controls. It is important to emphasize that the improvement in endothelial t-PA release occurred without concomitant changes in body mass and body composition and was accomplished with a moderate intensity home-based aerobic exercise training program that can be safely performed by most, if not all, overweight and obese adults. The fact that the capacity of the endothelium to release t-PA increased independent of weight loss or changes in body composition and lipid profile suggest a primary modulatory effect of aerobic exercise on endothelial fibrinolytic regulation. Several factors may underlie the exercise-induced increase in endothelial t-PA release capacity such as, shear stress-induced increases in endothelial t-PA mRNA signal expression and protein synthesis (12, 13) , and elevated intracellular calcium concentrations facilitating greater t-PA release upon stimulation (29) . In addition, we observed no change in CRP, IL-6, IL-18 and TNF-α with exercise training, further supporting the benign influence of these circulating inflammatory factors on endothelial t-PA release. Importantly from a public health perspective, our findings emphasize that overweight and obese persons can receive important cardioprotective effects from moderate regular aerobic exercise regardless of changes in adiposity. Improved endothelial fibrinolytic function may be a central mechanism underlying the reduced risk of CVD morbidity and mortality observed in overweight and obese adults who engage in regular physical activity (2).
There are two important experimental limitations of the present study that should be mentioned. First, as with all cross-sectional study designs, we cannot rule out that genetic and/or lifestyle factors may have influenced the results of our group comparisons. In an effort to minimize the influence of lifestyle behaviors we studied overweight and normal weight adults of similar age who were non-smokers, not currently taking medication that could influence endothelial function (i.e. statins) and who did not differ in habitual physical activity. Second, with respect to the exercise intervention, our study design is somewhat weakened by the lack of a non-exercise control group. However, the exercise training program used in the present study has been consistently shown to confer important vascular benefits such as improvements in central arterial compliance and endothelial vasomotor regulation in healthy middle-aged and t-PA was indeed a primary effect of the intervention.
In conclusion, the results of the present study indicate that the capacity of the endothelium to release t-PA is impaired in middle-aged overweight adults. Endothelial fibrinolytic dysfunction may contribute to the increased risk of atherothrombotic events associated with overweight and obesity. Importantly, impaired endothelial t-PA release is not a irreversible consequence of adiposity. Regular aerobic exercise, independent of weight loss, can significantly enhance endothelial fibrinolytic function in overweight and obese adults. Taken together, our findings support the postulate that regular exercise can alleviate some of the health risks associated with overweight and obesity. Values are mean+SEM, *P<0.05 vs before training. 
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